Results 1 to 10 of about 111,421 (336)

Future of image enhanced endoscopy of esophageal adenocarcinoma. [PDF]

open access: yesClin Endosc
Barrett’s esophagus is a premalignant precursor lesion of esophageal adenocarcinoma that affects approximately 1% of the population worldwide. Esophageal adenocarcinoma has a high mortality rate with a five-year survival of 15% to 20%. Early detection of
Parlar K, Cakir M, Ozer O, Sharma P.
europepmc   +2 more sources

The molecular biology of esophageal adenocarcinoma [PDF]

open access: bronzeJournal of Surgical Oncology, 2005
AbstractBackgroundBarrett's esophagus is an acquired metaplastic change that occurs in the distal esophagus secondary to chronic gastroesophageal reflux. This premalignant condition forms the most important risk factor for developing esophageal adenocarcinoma, which is an extremely aggressive tumor with a 5‐year survival rate of less than 25 ...
Linetta B. Koppert   +4 more
openalex   +5 more sources

Esophageal adenocarcinoma

open access: bronzeThe Annals of Thoracic Surgery, 2001
Jeffrey A. Hagen, Tom R. DeMeester
openalex   +4 more sources

Genetic Features of Metachronous Esophageal Cancer Developed in Hodgkin's Lymphoma or Breast Cancer Long-Term Survivors: An Exploratory Study. [PDF]

open access: yes, 2015
Background Development of novel therapeutic drugs and regimens for cancer treatment has led to improvements in patient long-term survival. This success has, however, been accompanied by the increased occurrence of second primary cancers.
Alfieri, R   +11 more
core   +14 more sources

Epidemiology of early esophageal adenocarcinoma [PDF]

open access: yesClinical Endoscopy, 2022
Background/Aims: Endoscopic resection has become the preferred treatment approach for select early esophageal adenocarcinoma (EAC); however, the epidemiology of early stage disease has not been well defined.Methods: Surveillance Epidemiology and End Results (SEER) data were analyzed to determine age-adjusted incidence rates among major epithelial ...
Thuy-Van P. Hang   +11 more
openaire   +3 more sources

The Epidemiology of Esophageal Adenocarcinoma [PDF]

open access: yesGastroenterology, 2018
The incidence of esophageal adenocarcinoma (EAC) has increased in many Western countries and is higher in men than women. Some risk factors for EAC have been identified-mainly gastroesophageal reflux disease, Barrett's esophagus, obesity, and tobacco smoking.
Shao-Hua Xie   +3 more
openaire   +6 more sources

Beyond Field Effect: Analysis of Shrunken Centroids in Normal Esophageal Epithelia Detects Concomitant Esophageal Adenocarcinoma

open access: yesBioinformatics and Biology Insights, 2007
Background and Aims Because of the extremely low neoplastic progression rate in Barrett's esophagus, it is difficult to diagnose patients with concomitant adenocarcinoma early in their disease course.
Florin M. Selaru   +13 more
doaj   +2 more sources

Risk of esophageal and gastric adenocarcinoma in men receiving androgen deprivation therapy for prostate cancer

open access: yesScientific Reports, 2021
The aim of this study was to explore the male predominance in esophageal and gastric adenocarcinoma by evaluating the preventive potential of androgen deprivation therapy (ADT).
Richard Shore   +7 more
doaj   +1 more source

Esophageal adenocarcinoma with metastasis to the prostatic urethra and bladder

open access: yesUrology Case Reports, 2023
Metastatic esophageal adenocarcinoma to the urinary bladder is extremely rare and aggressive. We discuss here the case of an 83-year-old male with history of esophageal adenocarcinoma treated with chemoradiation therapy and esophagectomy who presented ...
Olamide M. Olawoyin   +6 more
doaj   +1 more source

Transcribed ultraconserved noncoding RNAs (T-UCR) are involved in Barrett's esophagus carcinogenesis. [PDF]

open access: yes, 2014
Barretts esophagus (BE) involves a metaplastic replacement of native esophageal squamous epithelium (Sq) by columnar-intestinalized mucosa, and it is the main risk factor for Barrett-related adenocarcinoma (BAc).
Baffa, R   +17 more
core   +11 more sources

Home - About - Disclaimer - Privacy